Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05798572Completed
Randomised, double-blind trial in urolithiasis comparing Silodosin group with Placebo group (2 arms). Primary endpoint: Entrance to bladder time. Started Mar 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05798572.